223 related articles for article (PubMed ID: 28666971)
21. Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women.
Bhadricha H; Patel V; Singh AK; Savardekar L; Patil A; Surve S; Desai M
Sci Rep; 2021 Aug; 11(1):16155. PubMed ID: 34373550
[TBL] [Abstract][Full Text] [Related]
22. Autoimmunity as a trigger for structural bone damage in rheumatoid arthritis.
Schett G
Mod Rheumatol; 2017 Mar; 27(2):193-197. PubMed ID: 28051887
[TBL] [Abstract][Full Text] [Related]
23. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
Riggs BL; Khosla S; Melton LJ
J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
[TBL] [Abstract][Full Text] [Related]
24. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
Tyagi AM; Mansoori MN; Srivastava K; Khan MP; Kureel J; Dixit M; Shukla P; Trivedi R; Chattopadhyay N; Singh D
J Bone Miner Res; 2014 Sep; 29(9):1981-92. PubMed ID: 24677326
[TBL] [Abstract][Full Text] [Related]
25. Estrogen deficiency, T cells and bone loss.
Pacifici R
Cell Immunol; 2008; 252(1-2):68-80. PubMed ID: 17888417
[TBL] [Abstract][Full Text] [Related]
26. Variable domain glycosylation of ACPA-IgG: A missing link in the maturation of the ACPA response?
Kempers AC; Hafkenscheid L; Scherer HU; Toes REM
Clin Immunol; 2018 Jan; 186():34-37. PubMed ID: 28882619
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
28. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
Dempster DW; Lambing CL; Kostenuik PJ; Grauer A
Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513
[TBL] [Abstract][Full Text] [Related]
29. Fluorosis increases the risk of postmenopausal osteoporosis by stimulating interferon γ.
Lv YG; Kang L; Wu G
Biochem Biophys Res Commun; 2016 Oct; 479(2):372-379. PubMed ID: 27644876
[TBL] [Abstract][Full Text] [Related]
30. Postmenopausal hormone therapy and the risk of rheumatoid arthritis: results from the Swedish EIRA population-based case-control study.
Orellana C; Saevarsdottir S; Klareskog L; Karlson EW; Alfredsson L; Bengtsson C
Eur J Epidemiol; 2015 May; 30(5):449-57. PubMed ID: 25762170
[TBL] [Abstract][Full Text] [Related]
31. Anti-citrullinated protein antibodies in rheumatoid arthritis: a functional role for mast cells and basophils?
Suurmond J; Schuerwegh AJ; Toes RE
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i55-8. PubMed ID: 21339220
[TBL] [Abstract][Full Text] [Related]
32. Osteoporosis in rheumatoid arthritis.
Dequeker J; Maenaut K; Verwilghen J; Westhovens R
Clin Exp Rheumatol; 1995; 13 Suppl 12():S21-6. PubMed ID: 8846540
[TBL] [Abstract][Full Text] [Related]
33. [Cytokines in bone diseases. Cytokine and postmenopausal osteoporosis].
Inada M; Miyaura C
Clin Calcium; 2010 Oct; 20(10):1467-72. PubMed ID: 20890027
[TBL] [Abstract][Full Text] [Related]
34. Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
Chen YM; Chen HH; Huang WN; Liao TL; Chen JP; Chao WC; Lin CT; Hung WT; Hsieh CW; Hsieh TY; Chen YH; Chen DY
PLoS One; 2017; 12(11):e0188454. PubMed ID: 29155868
[TBL] [Abstract][Full Text] [Related]
35. Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis.
Meednu N; Zhang H; Owen T; Sun W; Wang V; Cistrone C; Rangel-Moreno J; Xing L; Anolik JH
Arthritis Rheumatol; 2016 Apr; 68(4):805-16. PubMed ID: 26554541
[TBL] [Abstract][Full Text] [Related]
36. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
[TBL] [Abstract][Full Text] [Related]
37. T-Cell Mediated Inflammation in Postmenopausal Osteoporosis.
Wu D; Cline-Smith A; Shashkova E; Perla A; Katyal A; Aurora R
Front Immunol; 2021; 12():687551. PubMed ID: 34276675
[TBL] [Abstract][Full Text] [Related]
38. The immune system and postmenopausal osteoporosis.
D'Amelio P
Immunol Invest; 2013; 42(7):544-54. PubMed ID: 24004058
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of increased interleukin-17A serum levels in postmenopausal estrogen deficiency.
Molnár I; Bohaty I; Somogyiné-Vári É
Menopause; 2014 Jul; 21(7):749-52. PubMed ID: 24253487
[TBL] [Abstract][Full Text] [Related]
40. Relationship Between RANK and RANKL Gene Polymorphisms with Osteoporosis in Rheumatoid Arthritis Patients.
Mohamed RH; Mohamed RH; El-Shahawy EE
Genet Test Mol Biomarkers; 2016 May; 20(5):249-54. PubMed ID: 26914636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
